Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

265
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
265
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

139
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
139
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

323
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
323

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large language models for detecting colorectal polyps in endoscopic images-further research is required.

Gut·2026
Same author

The Role of Hydrolysed Rice Formula in the Dietary Management of Infants with Cow's Milk Allergy: A UK Healthcare Perspective.

Nutrients·2026
Same author

Beyond "It's Just a Phase": A Review of Picky Eating in Children.

Nutrients·2026
Same author

An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial.

Nutrients·2026
Same author

Gelatin tannate in pediatric infectious gastroenteritis.

Translational gastroenterology and hepatology·2026
Same author

Infantile Colic: When to Suspect Cow's Milk Allergy.

Nutrients·2025
Same journal

A lysate of a multi-strain probiotic formulation inhibits cell growth and oxidative phosphorylation in colorectal cancer cells via a ceramide-mediated mechanism.

Beneficial microbes·2026
Same journal

Gut microbial differences and function in infants with gastroschisis: a pilot prospective cohort study.

Beneficial microbes·2026
Same journal

Infant gut microbiota composition and metabolism can be influenced by extensively hydrolysed casein in vitro.

Beneficial microbes·2026
Same journal

Gut commensal Bacteroides faecichinchillae, a potential novel candidate of next-generation probiotics targeting type 2 diabetes.

Beneficial microbes·2026
Same journal

Ultra long-lived plasma cells in the human small intestine produce microbiota-reactive IgA antibodies.

Beneficial microbes·2026
Same journal

Engraftment of staphylococcal strains on human skin can competitively displace native staphylococci.

Beneficial microbes·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2025

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

24.4K

Why do clinical guidelines for probiotics differ?

Z Weizman1, Y Vandenplas2

  • 1Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.

Beneficial Microbes
|July 3, 2024
PubMed
Summary
This summary is machine-generated.

Conflicting clinical guidelines for probiotics exist worldwide. This review examines these discrepancies, their causes, and methods to improve probiotic guideline quality for better patient care.

More Related Videos

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.4K
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

12.6K

Related Experiment Videos

Last Updated: Jun 22, 2025

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

24.4K
Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

19.4K
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

12.6K

Area of Science:

  • Microbiology and Clinical Medicine
  • Evidence-Based Practice

Background:

  • Clinical guidelines offer healthcare recommendations based on evidence and experience.
  • Discrepancies among global health organizations' guidelines are common.
  • Current clinical use guidelines for probiotics exhibit significant disagreement.

Purpose of the Study:

  • To present examples of conflicting probiotic clinical guidelines.
  • To identify reasons behind guideline variations.
  • To suggest improvements for developing and assessing high-quality probiotic guidelines.

Main Methods:

  • Literature review of existing probiotic clinical guidelines.
  • Analysis of common discrepancies and underlying causes.
  • Evaluation of quality improvement tools for clinical guidelines.

Main Results:

  • Demonstration of conflicting recommendations for probiotic use in various conditions.
  • Identification of factors like differing evidence interpretation and scope.
  • Overview of established methodologies for enhancing guideline rigor.

Conclusions:

  • Variability in probiotic guidelines necessitates critical assessment.
  • Standardized development and evaluation frameworks are crucial.
  • Improved guidelines will support appropriate clinical application of probiotics.